Candriam S.C.A. Raises Holdings in Allogene Therapeutics, Inc. $ALLO
MarketBeat
Candriam S.C.A. boosted its position in Allogene Therapeutics, Inc. (NASDAQ:ALLO - Free Report) by 30.0% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,997,318 shares of the company's stock after acquiring an additiona
NASDAQ:ALLO